CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
67.61
0%
Market Trading Hours* (UTC) Open now
Closes on Thursday at 15:30

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.23
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Germany
Commission on trade 0%
Key Stats
Prev. Close 67.61
Open 67.66
1-Year Change 244.85%
Day's Range 67.61 - 67.66
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 24, 2024 67.61 0.00 0.00% 67.61 67.61 67.61
Apr 23, 2024 67.61 0.00 0.00% 67.61 67.76 67.61
Apr 22, 2024 67.66 0.05 0.07% 67.61 67.71 67.61
Apr 19, 2024 67.56 -0.05 -0.07% 67.61 67.61 67.56
Apr 18, 2024 67.61 0.00 0.00% 67.61 67.66 67.56
Apr 17, 2024 67.61 0.05 0.07% 67.56 67.66 67.56
Apr 16, 2024 67.71 -0.10 -0.15% 67.81 67.86 66.91
Apr 15, 2024 67.81 0.05 0.07% 67.76 67.86 67.71
Apr 12, 2024 67.81 0.40 0.59% 67.41 67.86 67.41
Apr 11, 2024 67.46 0.45 0.67% 67.01 67.46 67.01
Apr 10, 2024 67.06 0.60 0.90% 66.46 67.06 66.46
Apr 9, 2024 66.96 0.30 0.45% 66.66 67.01 66.66
Apr 8, 2024 66.91 0.00 0.00% 66.91 67.01 66.81
Apr 5, 2024 66.96 -0.05 -0.07% 67.01 67.11 66.91
Apr 4, 2024 67.01 0.10 0.15% 66.91 67.11 66.91
Apr 3, 2024 67.11 0.05 0.07% 67.06 67.16 67.06
Apr 2, 2024 67.11 0.70 1.05% 66.41 67.16 66.41
Mar 28, 2024 67.11 0.00 0.00% 67.11 67.13 67.11
Mar 27, 2024 67.11 0.22 0.33% 66.89 67.13 66.89
Mar 26, 2024 67.09 0.04 0.06% 67.05 67.13 67.05

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Morphosys Company profile

About MorphoSys AG

MorphoSys AG develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. The Company's operating segments include Proprietary Development and Partnered Discovery. In the Proprietary Development segment, it develops therapeutic antibodies and peptides in the area of inflammatory disease and oncology. In the Partnered Discovery segment, the Company applies technologies for the research, development and optimization of therapeutic antibodies as drug candidates. The Company develops new treatments for patients suffering from serious diseases. Its technologies include HuCAL, which is a collection fully human antibodies and a system for their optimization; Ylanthia, which is an antibody library in Fab format, and Slonomics, an automated technology for gene synthesis and modification for the generation of gene libraries in a controlled process.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, MorphoSys AG revenues decreased 45% to EUR179.6M. Net loss totaled EUR514.5M vs. income of EUR97.9M. Revenues reflect USA and Canada segment decrease of 51% to EUR156.3M. Net loss reflects Impairment - Goodwill increase from EUR2.1M to EUR230.7M (expense), Other R&D increase of 80% to EUR153.1M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from EUR3.01 to -EUR15.40.

Equity composition

12/2008, 3-for-1 stock split.

Industry: Biotechnology & Medical Research (NEC)

Semmelweisstr. 7
PLANEGG
BAYERN 82152
DE

News

We’re partnering with Newsquawk

Filter out the noise and focus on the news that matters.

08:32, 23 April 2024

US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

15:56, 22 April 2024

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

People also watch

BTC/USD

63,467.95 Price
-1.260% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.52 Price
-2.770% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,319.34 Price
+0.120% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.40

US100

17,227.80 Price
-0.710% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading